|
|
|
MIRA INFORM REPORT
|
Report No. : |
490106 |
|
Report Date : |
05.02.2018 |
IDENTIFICATION DETAILS
|
Name : |
ZYDUS
HOSPIRA ONCOLOGY PRIVATE LIMITED (w.e.f.12.10.2007) |
|
|
|
|
Formerly Known
As : |
ZYDUS MAYNE ONCOLOGY PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Plot No.3, Pharmez, Special Economic Zone, |
|
Tel. No.: |
91-2717-663000 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2016 |
|
|
|
|
Date of
Incorporation : |
13.06.2005 |
|
|
|
|
Com. Reg. No.: |
04-046246 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 150.000 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24230GJ2005PTC046246 |
|
|
|
|
IEC No.: |
0806000406 |
|
|
|
|
GST No.: |
24AAACZ2327A1ZX |
|
|
|
|
TIN No.: |
24073603905 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACZ2327A |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturing of Anti-Cancer Drugs. [Registered Activity] |
|
|
|
|
No. of Employees
: |
Information declined by the Management |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A+ |
|
Credit Rating |
Explanation |
Rating Comments |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
Status : |
Excellent |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a joint venture between CADILA HEALTHCARE LIMITED and HOSPIRA AUSTRALIA PTY LTD and was incorporated in the year 2005 having fine track record. The company is engaged in manufacturing, exporting and importing of pharmaceutical products. Management has failed to file its financials for the year 2017 with Registrar of Companies. For the financial year 2016, the company has achieved 12.15% growth in its revenue as compared to previous year and has maintained decent profitability margin of 26.05% during the year. The sound financial profile of the company is reflected by its healthy solvency indicators due to zero debt balance sheet profile along with strong net worth base and comfortable liquidity position. Rating continue to derive strength from the company’s strong parentage being a joint venture between “CADILA HEALTHCARE LIMITED” and “HOSPIRA AUSTRALIA PTY LIMITED” that offers its support in the form of technical and operational guidance as well as financial support. However, these rating strengths are partially offset by exposure to intense completion in the international generics market, and growing regulatory scrutiny in emerging market, along with growing competition, substantial investment in infrastructure and R&D which impact in profitability pressure among the major players. Payments are seems to be regular and as per commitment. The company can be considered good for normal business dealings at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CRISIL |
|
Rating |
Long Term Rating = AA- |
|
Rating Explanation |
High degree of safety and very low credit risk. |
|
Date |
19.10.2016 |
|
|
|
|
Rating Agency Name |
CRISIL |
|
Rating |
Short Term Rating = A1+ |
|
Rating Explanation |
Very strong degree of safety and carry lowest credit risk. |
|
Date |
19.10.2016 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 05.02.2018.
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DECLINED
MANAGEMENT NON-COOPERATIVE
[Contact No: 91-2717-663106/
6633000]
LOCATIONS
|
Registered Office : |
Plot No.3, Pharmez, Special Economic Zone, |
|
Tel. No.: |
91-2717-663000/ 106 |
|
Fax No.: |
91-2717-663100 |
|
E-Mail : |
DIRECTORS
AS ON 31.03.2017
|
Name : |
Mr. Ganesh Narayan Nayak |
|
Designation : |
Director |
|
Address : |
3, Ashwamegh Part V, |
|
Date of Birth/Age : |
18.05.1955 |
|
Date of Appointment : |
24.01.2006 |
|
DIN No. : |
00017481 |
|
|
|
|
Name : |
Mr. Nitinkumar Dalsukhray Parekh |
|
Designation : |
Director |
|
Address : |
A-3, Aryaman Bungalows, Near Railway Crossing, Thaltej – Shilaj Road,
Ahmedabad – 380015, Gujarat, India |
|
Date of Birth/Age : |
09.02.1961 |
|
Date of Appointment : |
11.02.2014 |
|
DIN No. : |
00155570 |
|
|
|
|
Name : |
Mr. Shirish Gundopant Belapure |
|
Designation : |
Managing Director |
|
Address : |
3, Amramanjari Bungalow, Opposite Chitvan Plor, |
|
Date of Birth/Age : |
19.07.1953 |
|
Date of Appointment : |
16.07.2008 |
|
DIN No. : |
02219458 |
|
|
|
|
Name : |
Andrew David Chatfield |
|
Designation : |
Director |
|
Address : |
8, Thirlmere Crescent, Church Crookham, Hampshire, GU526RT, United Kingdom |
|
Date of Appointment : |
10.05.2016 |
|
DIN No.: |
07086776 |
|
|
|
|
Name : |
Balasubramanian Srinivasan |
|
Designation : |
Director |
|
Address : |
Rainenweg 136, Reinach BL, 4153, Switzerland |
|
Date of Appointment : |
04.08.2015 |
|
DIN No.: |
07121117 |
|
|
|
|
Name : |
Mr. Harish Rajendra Sadana |
|
Designation : |
Director |
|
Address : |
B-1003, Simandhar Tower Nr. Judges Bungalow, Bodakdev, Ahmedabad- 380054, Gujarat, India |
|
Date of Appointment : |
30.08.2016 |
|
DIN No.: |
00026483 |
|
|
|
|
Name : |
Mr. John Francis Kelly |
|
Designation : |
Director |
|
Address : |
300 Flintlock Road, Southport, Connecticut, 06890, United States of America |
|
Date of Appointment : |
03.11.2015 |
|
DIN No.: |
07328087 |
|
|
|
|
Name : |
Mr. Nitin Laxman Mahadev |
|
Designation : |
Director |
|
Address : |
22B Ocean St Millburn New Jersey 07041 Us |
|
Date of Appointment : |
10.05.2016 |
|
DIN No.: |
07492815 |
KEY EXECUTIVES
|
Name : |
Mr. Umesh Vinodray Parikh |
|
Designation : |
Company Secretary |
|
Address : |
B-7, Jineshwar Nagar Part-I, Near Gyanjyot School, Ranna Park,
Ghatlodia, Ahmedabad – 380061, Gujarat, India |
|
Date of Birth/Age : |
27.05.1968 |
|
Date of Appointment : |
17.11.2005 |
|
PAN No.: |
ACCPP4496R |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 31.03.2017
|
Names of Shareholders |
No. of Shares |
Percentage of Holding |
|
Hospira Australia Pty Limited, Australia |
7500000 |
50.00 |
|
Cadila Healthcare Limited, India |
7500000 |
50.00 |
|
|
|
|
|
Total |
15000000 |
100.00 |
AS ON 03.08.2017
|
Equity Share Breakup |
Percentage of Holding |
|
Category |
|
|
Promoters
– Body Corporate |
100.00 |
|
|
|
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturing of Anti-Cancer Drugs. [Registered Activity] |
||||
|
|
|
||||
|
Products : |
|
||||
|
|
|
||||
|
Brand Names : |
Not Available |
||||
|
|
|
||||
|
Agencies Held : |
Not Available |
||||
|
|
|
||||
|
Exports : |
Not Divulged |
||||
|
|
|
||||
|
Imports : |
Not Divulged |
||||
|
|
|
||||
|
Terms : |
|
||||
|
Selling : |
Not Divulged |
||||
|
|
|
||||
|
Purchasing : |
Not Divulged |
PRODUCTION STATUS: (NOT AVAILABLE)
GENERAL INFORMATION
|
Suppliers : |
|
|||||||||||||||
|
|
|
|||||||||||||||
|
Customers : |
|
|||||||||||||||
|
|
|
|||||||||||||||
|
No. of Employees : |
Information declined by the Management |
|||||||||||||||
|
|
|
|||||||||||||||
|
Bankers : |
· Bank of Baroda Ashram Road Branch, Near Vallabh Sadan, Ashram Road, Ahmedabad - 390009, Gujarat, India · Standard Chartered Bank H2 Connaught Circus, New Delhi - 110001, Delhi, India · The Hongkong and Shanghai Banking Corporation Limited |
|||||||||||||||
|
|
|
|||||||||||||||
|
Facilities : |
|
|
Auditors : |
|
|
Name : |
B S R and Company Chartered Accountants |
|
Address : |
Lodha Excelus, 1st,
Floor, Apollo mills compound, N M Joshi Marg, Mahalaxmi, Mumbai – 400011,
Maharashtra, India |
|
Income-tax
PAN of auditor or auditor's firm : |
AAIFB7357B |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Joint Venture : |
· Cadila Healthcare Limited, India [L24230GJ1995PLC025878] · Hospira Australia Pty Limited |
CAPITAL STRUCTURE
AS ON 31.03.2016
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
15000000 |
Equity Shares |
INR 10/- each |
INR 150.000 Million |
|
5000 |
Preference Shares |
INR 100000/-each |
INR 500.000 Million |
|
|
|
|
INR 650.000
Million |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
15000000 |
Equity Shares |
INR 10/- each |
INR 150.000
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
150.000 |
150.000 |
150.000 |
|
(b) Reserves and Surplus |
4280.750 |
3284.370 |
3088.810 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
4430.750 |
3434.370 |
3238.810 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Deferred tax liabilities (Net) |
50.740 |
44.610 |
18.690 |
|
(c) Other long-term
liabilities |
1.210 |
1.790 |
5.960 |
|
(d) long-term
provisions |
14.590 |
15.840 |
8.570 |
|
Total Non-current
Liabilities (3) |
66.540 |
62.240 |
33.220 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short-term
borrowings |
0.000 |
156.200 |
0.000 |
|
(b) Trade
payables |
345.150 |
667.590 |
245.330 |
|
(c) Other
current liabilities |
33.480 |
26.030 |
24.410 |
|
(d) Short-term
provisions |
15.700 |
7.540 |
1304.780 |
|
Total Current
Liabilities (4) |
394.330 |
857.360 |
1574.520 |
|
|
|
|
|
|
TOTAL |
4891.620 |
4353.970 |
4846.550 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
756.600 |
790.190 |
656.520 |
|
(ii)
Intangible Assets |
6.860 |
8.120 |
6.120 |
|
(iii) Tangible assets
capital work-in-progress |
328.410 |
332.350 |
501.610 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.000 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d)
Long-term loans and advances |
583.550 |
582.990 |
565.530 |
|
(e) Other
Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total Non-Current
Assets |
1675.420 |
1713.650 |
1729.780 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
709.140 |
10.750 |
375.480 |
|
(b)
Inventories |
1339.380 |
1292.250 |
1212.460 |
|
(c) Trade
receivables |
989.250 |
1228.750 |
728.530 |
|
(d) Cash and
bank balances |
85.380 |
93.620 |
724.030 |
|
(e)
Short-term loans and advances |
23.130 |
10.950 |
15.410 |
|
(f) Other
current assets |
69.920 |
4.000 |
60.860 |
|
Total
Current Assets |
3216.200 |
2640.320 |
3116.770 |
|
|
|
|
|
|
TOTAL |
4891.620 |
4353.970 |
4846.550 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
|
SALES |
|
|
|
|
|
Total
Revenue from operations |
3824.830 |
3410.500 |
4299.110 |
|
|
Other Income |
117.780 |
64.590 |
250.850 |
|
|
TOTAL (A) |
3942.610 |
3475.090 |
4549.960 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials
Consumed |
1836.890 |
1445.530 |
1556.830 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
201.330 |
(86.090) |
(33.980) |
|
|
Employee benefit expense |
163.460 |
138.470 |
108.080 |
|
|
CSR expenditure |
56.880 |
75.950 |
0.000 |
|
|
Other expenses |
313.410 |
267.480 |
203.370 |
|
|
TOTAL (B) |
2571.970 |
1841.340 |
1834.300 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION (C) |
1370.640 |
1633.750 |
2715.660 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
0.150 |
0.660 |
0.000 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION
(C-D) (E) |
1370.490 |
1633.090 |
2715.660 |
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
96.010 |
88.130 |
83.230 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) BEFORE
TAX (E-F) (G) |
1274.480 |
1544.960 |
2632.430 |
|
|
|
|
|
|
|
Less |
TAX (H) |
278.100 |
349.090 |
34.300 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
AFTER TAX (G-H) (I) |
996.380 |
1195.870 |
2598.130 |
|
|
|
|
|
|
|
|
EARNINGS IN FOREIGN
CURRENCY |
|
|
|
|
|
FOB value of export |
3708.520 |
|
|
|
|
Service income |
40.030 |
23.930 |
|
|
|
Reimbursement of expenses received |
0.510 |
0.070 |
|
|
|
TOTAL EARNINGS |
3749.060 |
3392.370 |
4239.930 |
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
Raw Materials |
1445.170 |
1184.570 |
1893.300 |
|
|
Stores & Spares |
32.890 |
21.010 |
11.640 |
|
|
Capital Goods |
24.330 |
15.320 |
224.60 |
|
|
TOTAL IMPORTS |
1502.390 |
1220.900 |
2129.540 |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per
Share (INR) |
66.43 |
79.72 |
173.21 |
CURRENT MATURITIES
OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current Maturities of Long term debt |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
Net cash flows from (used in) operations |
1193.630 |
1515.410 |
2611.850 |
|
|
|
|
|
|
Net cash flows from (used in) operating activities |
928.440 |
1172.300 |
2042.330 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Average Collection Days (Sundry
Debtors / Income * 365 Days) |
94.40 |
131.50 |
61.85 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry Debtors) |
3.87 |
2.78 |
5.90 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
68.58 |
168.57 |
57.52 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
1.02 |
1.26 |
2.24 |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
1.26 |
1.44 |
2.33 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Debt Ratio ((Borrowing
+ Current Liabilities) / Total Assets) |
0.08 |
0.20 |
0.32 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
0.00 |
0.05 |
0.00 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
0.09 |
0.25 |
0.49 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
0.25 |
0.33 |
0.36 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
9137.60 |
2475.38 |
0.00 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Net Profit Margin ((PAT / Sales) * 100) |
% |
26.05 |
35.06 |
60.43 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
20.37 |
27.47 |
53.61 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
22.49 |
34.82 |
80.22 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current Ratio (Current
Assets / Current Liabilities) |
8.16 |
3.08 |
1.98 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
4.76 |
1.57 |
1.21 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
0.91 |
0.79 |
0.67 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
0.00 |
1.04 |
0.00 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
8.16 |
3.08 |
1.98 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Share Capital |
150.000 |
150.000 |
150.000 |
|
Reserves & Surplus |
3088.810 |
3284.370 |
4280.750 |
|
Money received against share
warrants |
0.000 |
0.000 |
0.000 |
|
Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Net
worth |
3238.810 |
3434.370 |
4430.750 |
|
|
|
|
|
|
Long-term borrowings |
0.000 |
0.000 |
0.000 |
|
Short term borrowings |
0.000 |
156.200 |
0.000 |
|
Current maturities of
long-term debts |
0.000 |
0.000 |
0.000 |
|
Total
borrowings |
0.000 |
156.200 |
0.000 |
|
Debt/Equity
ratio |
0.000 |
0.045 |
0.000 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
4299.110 |
3410.500 |
3824.830 |
|
|
0.000 |
(20.670) |
12.149 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
4299.110 |
3410.500 |
3824.830 |
|
Profit/ (Loss) |
2598.130 |
1195.870 |
996.380 |
|
|
60.43
% |
35.06
% |
26.05
% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
No |
|
8 |
Designation of contact person |
No |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
No |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
No |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
Yes |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
INDEX OF CHARGES
|
SNO |
SRN |
CHARGE ID |
CHARGE HOLDER NAME |
DATE OF CREATION |
DATE OF MODIFICATION |
DATE OF SATISFACTION |
AMOUNT |
ADDRESS |
|
1 |
C19737519 |
10518982 |
ICICI Bank Limited |
26/08/2014 |
- |
- |
600000000.0 |
9th Floor, JMC HouseOpp. Parimal Garden, AmbawadiAhmedabadGJ380006IN |
|
2 |
C22843486 |
10211370 |
Standard Chartered Bank |
23/03/2010 |
11/09/2014 |
- |
300000000.0 |
ABHIJEET II, NEAR MITHAKHALI CROSS ROADSAHMEDABADGJ380006IN |
|
3 |
G06894109 |
10541626 |
The Hongkong and Shanghai Banking Corporation Limited |
15/12/2014 |
- |
10/06/2016 |
250000000.0 |
IndiaBulls Finance CentreTower III- 26th Floor Elphistone RoadmumbaiMH400013IN |
|
4 |
C14373120 |
10061027 |
BANK OF BARODA |
10/05/2007 |
04/08/2010 |
15/07/2014 |
300000000.0 |
ASHRAM ROAD BRANCHNEAR VALLABH SADANAHMEDABADGJ390009IN |
|
5 |
C14374847 |
10040214 |
BANK OF BARODA |
19/02/2007 |
04/08/2010 |
15/07/2014 |
300000000.0 |
ASHRAM ROAD BRANCHNEAR VALLABH SADANAHMEDABADGJ390009IN |
|
6 |
C14374268 |
10041518 |
BANK OF BARODA |
19/02/2007 |
13/08/2010 |
15/07/2014 |
850000000.0 |
ASHRAM ROAD BRANCHNEAR VALLABH SADAN, ASHRAM ROADAHMEDABADGJ390009IN |
|
7 |
A11061637 |
10006753 |
ICICI BANK LIMITED |
09/06/2006 |
- |
22/02/2007 |
100000000.0 |
LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN |
BACKGROUND
Zydus Hospira Oncology Private Limited (the Company) is a Joint Venture between Cadila Healthcare Limited and Hospira Australia Pty Limited, incorporated in Australia. The Company is manufacturing anti-cancer formulations in Pharmez, Special Economic Zone near Ahmedabad. The Company had started the commercial production on 1 May 2009.
OPERATIONS AND
BUSINESS PERFORMANCE
During the year which the Seventh year of commercial operations, the Company has achieved Sa les of I NR 37 53.270 Million. Export Sa les of the Company is 99.87 % of the total sales of the Company. Net profit after tax is INR 996.380 Million.
CHANGE OF ADDRESS:
The Registered Office of the company has been shifted from Zydus Tower Satelite Crsoo Road, Sarkhej,
Gandhi Nagar, Highway, Ahmedabad - 380015, Gujarat, India to the present address w.e.f 19.07.2007
CONTINGENT
LIABILITIES:
|
Particulars |
31.03.2016 (INR
In Million) |
31.03.2015 (INR
In Million) |
|
Claims against company not acknowledged as debt |
3.870 |
0.000 |
FIXED ASSETS:
Tangible Assets
·
Land
·
Buildings
·
Plant and Equipment
·
Furniture and Fixtures
·
Vehicles
·
Office Equipment
·
Computer Equipments
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 64.08 |
|
UK Pound |
1 |
INR 91.34 |
|
Euro |
1 |
INR 80.03 |
INFORMATION DETAILS
|
Information
Gathered by : |
SAV |
|
|
|
|
Analysis Done by
: |
NIS |
|
|
|
|
Report Prepared
by : |
IND |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably on
secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the business
is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.